DIL that occurs secondary to TNF-α inhibitor treatment frequently produces a fever, arthritis, arthralgia, and/or a skin rash, and it only rarely causes hematological, renal, or central nervous system manifestations. The gene discussed is TNF; the disease is drug-induced lupus erythematosus.